Functional activity of albumin and hemostasis disorders in cancer patients with purulent septic complications


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The development of purulent-septic complications in cancer patients after surgery complicates the course of the postoperative period. One of the ways to solve the problem is to search for markers that make it possible to diagnose as early as possible, evaluate treatment and predict the outcome of infectious complications. Preliminary studies have shown abnormalities in the detoxification function of serum albumin in cancer patients as a prognostic marker of the occurrence of purulent-septic complications in the postoperative period. In addition, purulent-septic complications are one of the most frequent causes of disorders in the hemostatic system, from isolated thrombocytopenia to acute disseminated intravascular coagulation, which complicate the course of the postoperative period. The aim of this work is to assess the diagnostic significance of indicators of the functional activity of albumin, biomarkers of sepsis and the state of the hemostasis system in cancer patients with purulent-septic complications. The studies have shown that the indicator of the detoxification efficiency of serum albumin, determined already on the first day of the development of septic complications and in dynamics within 20 days after the operation, is a laboratory indicator of the prognosis of the course of these complications in cancer patients. In cancer patients, a significant increase in presepsin (an early marker of sepsis) is observed already from the first day of the development of purulent-septic complications (up to 1986 pg/m) and after 1-2 days procalcitonin rises (up to 112 ng/ml). A significant activation of blood coagulation and the development of various forms of DIC syndrome with the consumption of natural thrombin inhibitors, fibrinolysis components and platelets must be taken into account in the complex therapy of septic conditions. The results of evaluating the effectiveness of the detoxification activity of albumin, the level of presepsin and procalcitonin, the assessment of the intensity of intravascular blood coagulation can be used to accompany cancer patients during surgical treatment and timely detection of purulent-septic complications, which significantly aggravate the course of the postoperative period, lengthen the time of hospital stay and increase the cost of treatment.

Full Text

Restricted Access

About the authors

O. V Somonova

N.N. Blokhin National Medical Research Center of Oncology

Email: somonova@mail.ru
Dr.Sci. (Med.), Senior Research Scientist

A. L Elizarova

N.N. Blokhin National Medical Research Center of Oncology

Ph.D. (Biol.), Senior Research Scientist

T. V Davydova

N.N. Blokhin National Medical Research Center of Oncology

Ph.D. (Biol.), Head of Laboratory of Clinical Diagnostic

A. V Cytov

N.N. Blokhin National Medical Research Center of Oncology

Ph.D. (Med.), Head of Department of Anesthesiology and Reanimatology

N. N Borisenko

N.N. Blokhin National Medical Research Center of Oncology

Junior Research Scientist

U. A Kornyushenko

N.N. Blokhin National Medical Research Center of Oncology

Junior Research Scientist

E. G Golovnya

N.N. Blokhin National Medical Research Center of Oncology

Junior Research Scientist

J. A Nesterova

N.N. Blokhin National Medical Research Center of Oncology

Junior Research Scientist

M. M Dobrovolskaya

N.N. Blokhin National Medical Research Center of Oncology

Ph.D. (Biol.), Junior Research Scientist

References

  1. Shankar-Hari М., Philips G.S., Levy M.L., et al. Developing a new definition and assessing new clinical criteria for septic shock; For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016; 315(8):885-787.
  2. Сепсис: избранные вопросы диагностики и лечения. Практическое руководство / Под ред. Н.В. Дмитриевой, И.Н. Петуховой, Е.Г. Громовой. М.: ИД «АБВ-пресс». 2018.416 с.
  3. Воробьев П.А. Тромбоцитарно-эндотелиальные взаимодействия - теория старения и горизонты геропротекции. Клиническая геронтология. 2011; 12:3-8.
  4. Андреева О.Л. Изменение связывающих центров сывороточного альбумина в оценке состояния организма при различных патологиях: Автореф. дисс.. докт. биол. наук. Екатеринбург, 2003. 226 с.
  5. Воробьев П.А., Безмелъницына Л.Ю., Краснова Л.С., Холовня М.А., Матвеева И.И., Давыдова Т.В., Нехаев И.В., Сытов А.В., Нерсесян М.Ю. Клинико-экономический анализ эффективности применения АТА-теста для ранней диагностики послеоперационных гнойно-септических осложнений. Проблемы стандартизации в здравоохранении. 2014; 3-4:28-36.
  6. Белобородова Н.В., Попов ДА. Тест на прокальцитонин: алгоритмы применения и новые возможности: Пособие для врачей. М.: Директ-Медиа, 2008. 230 с.
  7. Dellinger R.P., Levy М.М., Rhodes A., et al. Surviving sepsis campagn: international guidelines for management of severe sepsis and septic shock: 2012. Critical Care Med. 2013; 41(2):580-637.
  8. Наука. Технология ЭПР - Методика. [Электронный ресурс]. Режим flocTyna:http://www.medinnovation.eu/ru/ science/tehnologia-epr-etodika.html (дата обращения 2019-06-19).
  9. Lowenthal M.S., Mehta A.L., Frogale К., et al. Analysis of albumin-associated peptides and proteins from ovarian cancer patients. Clin. Chem. 2005; 51(10): 1933-1945.
  10. Давыдова T.B., Матвеева И.И., Сытов A.B., Нехаев И.В., Свиридова С.П. Диагностика и мониторинг развития гнойно-септических осложнений в раннем послеоперационном периоде у онкологических больных с помощью ЭПР-метода. Int. J. Appl. Fund. Res. 2011; 5:94-95.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2020 Russkiy Vrach Publishing House

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies